4
Changes in Ownership
RIGEL PHARMACEUTICALS INC Filed Acc 0000905148-26-003076
Director sold 2,500 shares at $35.00 ($87,500)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ali-Jackson Kamil · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-22 | Sale : show line 1 in the form 10b5-1 | −2,500 | $35.00 | $87,500 | 10,125 | D |
| Open-market sales · 2,500 sh · avg $35.00 · $87,500 | ||||||
Loading xslF345X06/form4.xml…